Ignite Creation Date:
2024-07-17 @ 11:35 AM
Last Modification Date:
2024-10-26 @ 3:32 PM
Study NCT ID:
NCT06463171
Status:
NOT_YET_RECRUITING
Last Update Posted:
2024-06-17
First Post:
2024-06-10
Brief Title:
Phase II Trial of Almonertinib Plus Lastet for EGFR Non-small Cell Lung Cancer
Sponsor:
Organization:
Shanghai Pulmonary Hospital Shanghai China